Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,006 DKK | +0.30% | +1.79% | +44.05% |
Jun. 28 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
Jun. 28 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.05% | 641B | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B | |
+0.20% | 120B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : Goldman Sachs reiterates its Buy rating